Prothena | PRTA - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Exelixis USD 252.69M 275K 2025-12
Immunic USD -21.38M 8.2M 2024-06
Incyte USD 389.94M 92.37M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
MacroGenics USD 16.82M 52.97M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Prothena USD -36.91M 44.05M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06